Tim Wallis

Ridgeway Biological’s Managing Director, Tim Wallis, is one of the worlds leading experts onbacterial pathogenesis having done a degree in Microbiology at the University of Leeds, and a PhD at the University of Birmingham studying Salmonella pathogenesis. He headed the Mammalian Enteric Pathogens research group at the Institute for Animal Health from 1992-2005 before leaving the Institute to oversee the expansion of Ridgeway Biologicals Ltd. His research focused on the virulence factors of Salmonella and E.coli that influence colonisation and pathogenesis in food producing animals of these important zoonotic pathogens. Such information is key to the understanding the infection and immunity of bacterial infections and vaccine development.

Carlos Alberto Kuada

Randolph Richards

Randolph is Professor of Clinical Pathology. He is a veterinarian with many years’ experience in the field of fish health. He is especially knowledgeable about drug interactions and therapeutic approaches to disease control.

Dr. Funing Zhong

Rimma Berenstein

Daniel Bonn

Daniel Bonn is director of the Institute of Physics of the University of Amsterdam, where over 200 researchers work. He is also group leader of the Complex Fluids Group, which studies the flow behavior of surfactant, polymer and colloid systems, and  totals about 30 people. Before coming to Amsterdam recently, he was a CNRS research director at the prestigious Ecole Normale Supérieure in Paris, where he led the ‘complex fluids’ group. He published more than 200 papers on wetting, complex fluids and hydrodynamics and was invited more than 40 times as a speaker at international conferences In the past five years. Daniel Bonn has a large amount of industrial collaborations such as with Michelin, SKF and Unilever, Shell,  DSM, Akzo Nobel, ASML etc. Bonn is also co-founder of the startup company GreenA that just received a Round A investment from a venture capital firm and now employs several people.